MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, KYTX has $293,826K in assets. $61,550K in debts. $124,093K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
775.49%
Quick Ratio
775.49%
Cash Ratio
340.10%
Debt to Asset Ratio
20.95%
Unit: Thousand (K) dollars
Assets Breakdown
    • Available-for-sale marketable se...
    • Cash and cash equivalents
    • Other non-current assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Term loan
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
124,093
Available-for-sale marketable securities
155,160
Prepaid expenses and other current assets
3,700
Total current assets
282,953
Restricted cash
551
Property and equipment, gross
5,296
Less accumulated depreciation
3,750
Property and equipment, net
1,546
Operating lease right-of-use assets
3,568
Finance lease right-of-use assets
305
Other non-current assets
4,903
Total assets
293,826
Accounts payable
5,306
Accrued compensation
9,990
Accrued license expense - related party
3,750
Other accrued expenses and current liabilities
13,472
Operating lease liabilities, short-term portion
3,662
Finance lease liabilities, short-term portion
307
Total current liabilities
36,487
Operating lease liabilities, net of short-term portion
320
Finance lease liabilities, net of short-term portion
0
Term loan
24,743
Total liabilities
61,550
Common stock, 0.00001 par value 490,000,000 shares authorized as of december 31, 2025 and 2024, respectively 60,389,893 and 43,214,918 shares issued and outstanding as of december 31, 2025 and 2024, respectively
1
Additional paid-in capital
657,005
Accumulated other comprehensive income
97
Accumulated deficit
-424,827
Total stockholders' equity
232,276
Total liabilities and stockholders' equity
293,826
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Available-for-sale marketablesecurities$155,160K Cash and cashequivalents$124,093K Prepaid expenses andother current assets$3,700K Property and equipment,gross$5,296K Total current assets$282,953K Other non-currentassets$4,903K Operating leaseright-of-use assets$3,568K Property and equipment,net$1,546K Restricted cash$551K Finance leaseright-of-use assets$305K Less accumulateddepreciation$3,750K Total assets$293,826K Total liabilities andstockholders' equity$293,826K Total stockholders'equity$232,276K Total liabilities$61,550K Accumulated deficit-$424,827K Additional paid-in capital$657,005K Total currentliabilities$36,487K Term loan$24,743K Operating leaseliabilities, net of...$320K Accumulated othercomprehensive income$97K Common stock, 0.00001par value...$1K Other accruedexpenses and current...$13,472K Accrued compensation$9,990K Accounts payable$5,306K Accrued license expense- related party$3,750K Operating leaseliabilities, short-term...$3,662K Finance leaseliabilities, short-term...$307K

Kyverna Therapeutics, Inc. (KYTX)

Kyverna Therapeutics, Inc. (KYTX)